Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03191604 · ClinicalTrials.gov registry record
Impact of NBI on Patients Undergoing Endoscopic Eradication Therapy
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 46
- Enrollment target
NCT03191604 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 46 participants.
The verdict
NCT03191604 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
This study tests the impact of narrow band imaging (NBI) on endoscopists' accurate detection of visible lesions and dysplasia in patients with Barrett's esophagus, as well as the effect of NBI on the choice of primary treatment modality among endoscopists performing endoscopic eradication therapy (EET).
Interventions
- OTHER Video intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2017-11-01 |
| Est. Completion | 2019-05-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03191604
The ClinicalTrials.gov registry entry for NCT03191604 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Video intervention is the first listed.
NCT03191604 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03191604 about?
NCT03191604 is a clinical study titled "Impact of NBI on Patients Undergoing Endoscopic Eradication Therapy". This study tests the impact of narrow band imaging (NBI) on endoscopists' accurate detection of visible lesions and dysplasia in patients with Barrett's esophagus, as well as the effect of NBI on the choice of primary treatment modality among endoscopists performing endoscopic eradication therapy (E...
What is the current status of trial NCT03191604?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2017-11-01. Estimated completion is 2019-05-10.
What interventions are being tested in trial NCT03191604?
The interventions under investigation include: Video intervention (OTHER).
Who is sponsoring clinical trial NCT03191604?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.